FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

Medicrea 3D-printed Titanium Interbodt Devices Cleared

FDA clears a Medicrea Group 510(k) for its IB3D range of 3D-printed Titanium interbody devices with its AdapTEK in-house additive manufacturing platfo...

Human Drugs

Janssen Files sBLA for Datzalex in Multiple Myeloma

Janssen Biotech files a supplemental BLA for Darzalex (daratumumab) and its expanded use in combination with bortezomib, melphalan and prednisone for ...

Medical Devices

FDA Approves Adjustable Implanted Cataract Lens

FDA approves a RxSight adjustable intraocular lens for use following cataract surgery.

FDA General

Latest FDA Warning Letters

FDA releases its latest batch of Warning Letters that includes Hubei Danjiangkou Danao Pharmaceutical and Vita-Pure.

Human Drugs

Abuse-Deterrent Generic Opioid Guidance

FDA commissioner Scott Gottlieb says the agency has issued a new guidance and taken other steps to help sponsors test and seek approval for generic ab...

Federal Register

Comments Sought on Info Collection Under 513(g) Devices

Federal Register notice: FDA seeks comments on an information collection extension for 513(g) Request for Information OMB Control Number 0910-0705.

Human Drugs

Cytokinetics Suspends ALS Drug Program After Phase 3 Data

Cytokinetics suspends its tirasemtiv drug development program after receiving disappointing data from the VITALITY-ALS Phase 3 clinical trial in patie...

Human Drugs

Trintellix Not Withdrawn Due to Safety/Effectiveness: FDA

Federal Register notice: FDA determines that Takedas Trintellix (vortioxetine hydrobromide) oral tablet, indicated for treating major depressive disor...

Federal Register

Comments Sought on Device Accredited Person Inspections

Federal Register notice: FDA seeks comments on an information collection extension for its guidance on Notification of the Intent To Use an Accredited...

Human Drugs

2-drug Combination Approved for Treating HIV-1

FDA approves a ViiV Healthcare NDA for Juluca, the first complete treatment regimen containing two drugs to treat certain adults with human immunodefi...